BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35260133)

  • 21. Increased salivary AKR1B10 level: Association with progression and poor prognosis of oral squamous cell carcinoma.
    Ko HH; Peng HH; Cheng SJ; Kuo MY
    Head Neck; 2018 Dec; 40(12):2642-2647. PubMed ID: 30430672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of tumor marker CA 125 in saliva of normal and oral squamous cell carcinoma patients: a comparative study.
    Balan JJ; Rao RS; Premalatha BR; Patil S
    J Contemp Dent Pract; 2012 Sep; 13(5):671-5. PubMed ID: 23250173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.
    Csősz É; Lábiscsák P; Kalló G; Márkus B; Emri M; Szabó A; Tar I; Tőzsér J; Kiss C; Márton I
    PLoS One; 2017; 12(5):e0177282. PubMed ID: 28545132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of salivary MMP-9 in oral squamous cell carcinoma and oral leukoplakia using ELISA.
    Pazhani J; Chanthu K; Jayaraman S; Varun BR
    J Oral Maxillofac Pathol; 2023; 27(4):649-654. PubMed ID: 38304520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
    Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
    BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study.
    Lan Q; Zhang C; Hua H; Hu X
    BMC Oral Health; 2023 Dec; 23(1):1021. PubMed ID: 38115005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of salivary lactate dehydrogenase in oral squamous cell carcinoma, oral leukoplakia, and smokers.
    Bhuvaneswari M; Prasad H; Rajmohan M; Sri Chinthu KK; Prema P; Mahalakshmi L; Kumar GS
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S215-S218. PubMed ID: 36510967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salivary melatonin in oral squamous cell carcinoma patients.
    Salarić I; Karmelić I; Lovrić J; Baždarić K; Rožman M; Čvrljević I; Zajc I; Brajdić D; Macan D
    Sci Rep; 2021 Jun; 11(1):13201. PubMed ID: 34168230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer.
    Horváth J; Szabó A; Tar I; Dezső B; Kiss C; Márton I; Scholtz B
    Pathol Oncol Res; 2018 Oct; 24(4):833-842. PubMed ID: 28861772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased salivary microvesicles are associated with the prognosis of patients with oral squamous cell carcinoma.
    Zhong WQ; Ren JG; Xiong XP; Man QW; Zhang W; Gao L; Li C; Liu B; Sun ZJ; Jia J; Zhang WF; Zhao YF; Chen G
    J Cell Mol Med; 2019 Jun; 23(6):4054-4062. PubMed ID: 30907490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of Salivary Markers, IL-1β, IL-8 and Lgals3bp for Detection of Oral Squamous Cell Carcinoma in an Indian Population.
    Singh P; Verma JK; Singh JK
    Sci Rep; 2020 Apr; 10(1):7365. PubMed ID: 32355279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma.
    Nakamichi E; Sakakura H; Mii S; Yamamoto N; Hibi H; Asai M; Takahashi M
    Oral Dis; 2021 Apr; 27(3):439-447. PubMed ID: 32688445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Papillary Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma: A Histopathological and Immunohistochemical Comparative Study.
    Mahmoud EA; Abdellatif MK; Mahmoud SAM
    Head Neck Pathol; 2024 Jun; 18(1):47. PubMed ID: 38884825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of potential salivary biomarker panels for oral squamous cell carcinoma.
    Jain A; Kotimoole CN; Ghoshal S; Bakshi J; Chatterjee A; Prasad TSK; Pal A
    Sci Rep; 2021 Feb; 11(1):3365. PubMed ID: 33564003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS.
    Jou YJ; Hua CH; Lin CD; Lai CH; Huang SH; Tsai MH; Kao JY; Lin CW
    Clin Chim Acta; 2014 Sep; 436():121-9. PubMed ID: 24863804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α1 adrenergic receptors in serum and saliva of patients with oral squamous cell carcinoma.
    Gholizadeh N; Mohebbi AH; Mirzaii-Dizgah I; Sheykhbahaei N
    Clin Transl Oncol; 2021 Aug; 23(8):1705-1710. PubMed ID: 33644847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological differentiation of oral squamous cell carcinoma and salivary lactate dehydrogenase: A biochemical study.
    D'Cruz AM; Pathiyil V
    South Asian J Cancer; 2015; 4(2):58-60. PubMed ID: 25992341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical validation of a saliva-based matrix metalloproteinase-1 rapid strip test for detection of oral cavity cancer.
    Chu LJ; Chang YT; Chien CY; Chung HC; Wu SF; Chen CJ; Liu YC; Liao WC; Chen CH; Chiang WF; Chang KP; Wang JS; Yu JS
    Biomed J; 2024 Feb; 47(1):100594. PubMed ID: 37044249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of salivary transferrin in patients with oral squamous cell carcinoma.
    Tavakoli F; Ghavimi MA; Fakhrzadeh V; Abdolzadeh D; Afshari A; Eslami H
    Clin Exp Dent Res; 2024 Feb; 10(1):e809. PubMed ID: 37964689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.